Synthesis and expression of CDw75 antigen in human colorectal cancer
Open Access
- 10 December 2009
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 431
Abstract
Background: Increased ST6Gal I activity has been associated with the α(2,6)sialylation enhancement of membrane glycoconjugates observed in metastatic colorectal carcinomas (CRC). Siaα(2,6)Galβ(1,4)GlcNAc sequence, known as CDw75, is a sialylated carbohydrate determinant generated by the ST6Gal I. This epitope has been reported to be associated with the progression of gastric and colorectal tumours, hence there are only a few conclusive studies to date. Methods: By radioisotopic techniques we evaluated the ST6Gal I activity in healthy, transitional and tumour tissues from 43 patients with CRC. By immunohistochemistry we assessed the CDw75 expression in 25 colorectal adenomas, 43 tumours, 13 transitional and 28 healthy tissues of CRC patients. Results: ST6Gal I activity was likewise found to be statistically higher in tumour tissue respect to healthy tissue from CRC patients. CDw75 expression was positive in 20% of colorectal adenomas. Furthermore, 70% of tumour specimens and 8.3% of transitional specimens were positive for CDw75 expression, whereas none of the healthy ones showed the presence of the epitope. Conclusion: The major contribution of this study is the inclusion of data from transitional tissue and the analysis of CDw75 antigen expression in CRC and in colorectal adenomas, little known so far. ST6Gal I activity and CDw75 antigen expression were increased in CRC. Although their comparison did not reach the statistical significance, a great extent of patients showed both, an enhanced tumour ST6Gal I activity and an increased CDw75 expression in the tumour tissue. So, these two variables may play a role in malignant transformation. The expression of CDw75 in colorectal adenomas suggests that this antigen may be a tumour marker in CRC.Keywords
This publication has 33 references indexed in Scilit:
- Elevation of ST6Gal I Activity in Malignant and Transitional Tissue in Human Colorectal CancerOncology, 2005
- Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948Glycobiology, 2005
- Ras oncogene induces β‐galactoside α2,6‐sialyltransferase (ST6Gal I) via a RalGEF‐mediated signal to its housekeeping promoterEuropean Journal of Biochemistry, 2004
- Identification and functional expression of a second human β‐galactoside α2,6‐sialyltransferase, ST6Gal IIEuropean Journal of Biochemistry, 2003
- Clinicopathologic evaluation of CDw75 antigen expression in patients with gastric carcinomaThe Journal of Pathology, 2001
- β-galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity withsambucus nigra agglutininInternational Journal of Cancer, 2000
- Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer PatientsHybridoma, 2000
- Differentiation-dependent expression of human?-galactoside?2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cellsGlycoconjugate Journal, 1996
- CDw75 Antigen expression in human gastric carcinoma and adjacent mucosaCancer, 1993
- Transitional mucosa in human colorectal lesionsDiseases of the Colon & Rectum, 1990